Vanguard Group’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46M | Buy |
|
|||||
|
2025
Q1 | $6.83M | Buy |
|
|||||
|
2024
Q4 | $7.18M | Buy |
|
|||||
|
2024
Q3 | $1.39M | Buy |
|
|||||
|
2024
Q2 | $889K | Hold |
|
|||||
|
2024
Q1 | $1.71M | Hold |
|
|||||
|
2023
Q4 | $802K | Hold |
|
|||||
|
2023
Q3 | $714K | Hold |
|
|||||
|
2023
Q2 | $1.02M | Hold |
|
|||||
|
2023
Q1 | $1.34M | Hold |
|
|||||
|
2022
Q4 | $1.15M | Buy |
|
|||||
|
2022
Q3 | $1.26M | Sell |
|
|||||
|
2022
Q2 | $1.25M | Hold |
|
|||||
|
2022
Q1 | $2.18M | Sell |
|
|||||
|
2021
Q4 | $2.94M | Sell |
|
|||||
|
2021
Q3 | $3.02M | Sell |
|
|||||
|
2021
Q2 | $4.26M | Sell |
|
|||||
|
2021
Q1 | $7.19M | Buy |
|
|||||
|
2020
Q4 | $3.92M | Buy |
|
|||||
|
2020
Q3 | $329K | Buy |
|
|||||
|
2020
Q2 | $510K | Buy |
|
|||||
|
2020
Q1 | $212K | Buy |
|
|||||
|
2019
Q4 | $36K | Hold |
|
|||||
|
2019
Q3 | $23K | Hold |
|
|||||
|
2019
Q2 | $37K | Sell |
|
|||||
|
2019
Q1 | $118K | Buy |
|
|||||
|
2018
Q4 | $495K | Buy |
|
|||||
|
2018
Q3 | $408K | Buy |
|
|||||
|
2018
Q2 | $352K | Sell |
|
|||||
|
2018
Q1 | $520K | Sell |
|
|||||
|
2017
Q4 | $399K | Buy |
|
|||||
|
2017
Q3 | $417K | Buy |
|
|||||
|
2017
Q2 | $310K | Sell |
|
|||||
|
2017
Q1 | $416K | Buy |
|
|||||
|
2016
Q4 | $363K | Buy |
|
|||||
|
2016
Q3 | $1.37M | Buy |
|
|||||
|
2016
Q2 | $1.08M | Sell |
|
|||||
|
2016
Q1 | $1.15M | Buy |
|
|||||
|
2015
Q4 | $2.31M | Buy |
|
|||||
|
2015
Q3 | $2.03M | Sell |
|
|||||
|
2015
Q2 | $3.13M | Sell |
|
|||||
|
2015
Q1 | $2.38M | Buy |
|
|||||
|
2014
Q4 | $1.97M | Buy |
|